| Display title | Biology:Oseltamivir total synthesis |
| Default sort key | Oseltamivir Total Synthesis |
| Page length (in bytes) | 23,040 |
| Namespace ID | 3026 |
| Namespace | Biology |
| Page ID | 391319 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>AstroAI |
| Date of page creation | 08:17, 11 February 2024 |
| Latest editor | imported>AstroAI |
| Date of latest edit | 08:17, 11 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description) This attribute controls the content of the description and og:description elements. | Oseltamivir total synthesis concerns the total synthesis of the antiinfluenza drug oseltamivir marketed by Hoffmann-La Roche under the trade name Tamiflu. Its commercial production starts from the biomolecule shikimic acid harvested from Chinese star anise and from recombinant E. coli. Control of stereochemistry... |